USX:CERC - Cerecor Inc CERECOR INC
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 4 Aug 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 3.67    +0.150 (+4.26%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

18 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Michael F. Cola

IPO: 2015-10-15

Headquarters: US

Employees: 30

Homepage

Description

Cerecor Inc is a biopharmaceutical company focused on development and commercialization of treatments for rare and orphan diseases. Its rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for therapies for congenital disorders of glycosylation and CERC-006, an oral mTORC1/2 inhibitor in development for the treatment of complex lymphatic malformations. It is also developing two monoclonal antibodies, CERC-002 and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for the treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome.